A study involving thousands of participants has demonstrated the efficacy of a non-invasive cancer blood test for the accurate detection of more than 50 different types of the disease. The results of the multi-institute trial were published in the Annals of Oncologyand could pave the way for earlier detection of cancers not easily diagnosed by current screening methods.
Researchers led by the Dana-Farber Cancer Institute (MA, USA) and the Mayo Clinic (MN, USA) utilized the test to screen blood samples from 6689 individuals. The test, developed by GRAIL Inc. (CA, USA), was able to accurately detect the location of the cancer within the body; however, it demonstrated greater sensitivity when detecting later stage cancers.
To view the full article, please register now for access